Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1IJB

The von Willebrand Factor mutant (I546V) A1 domain

1IJB の概要
エントリーDOI10.2210/pdb1ijb/pdb
関連するPDBエントリー1AUQ 1IJK
分子名称von Willebrand factor (2 entities in total)
機能のキーワードdinucleotide-binding fold, blood clotting
由来する生物種Homo sapiens (human)
細胞内の位置Secreted: P04275
タンパク質・核酸の鎖数1
化学式量合計23125.79
構造登録者
Fukuda, K.,Doggett, T.A.,Bankston, L.A.,Cruz, M.A.,Diacovo, T.G.,Liddington, R.C. (登録日: 2001-04-25, 公開日: 2002-07-10, 最終更新日: 2024-10-30)
主引用文献Fukuda, K.,Doggett, T.A.,Bankston, L.A.,Cruz, M.A.,Diacovo, T.G.,Liddington, R.C.
Structural basis of von Willebrand factor activation by the snake toxin botrocetin.
Structure, 10:943-950, 2002
Cited by
PubMed Abstract: The A1 domain of von Willebrand factor (vWF) mediates platelet adhesion to sites of vascular injury by binding to the platelet receptor glycoprotein Ib (GpIb), an interaction that is regulated by hydrodynamic shear forces. The GpIb binding surface of A1 is distinct from a regulatory region, suggesting that ligand binding is controlled allosterically. Here we report the crystal structures of the "gain-of-function" mutant A1 domain (I546V) and its complex with the exogenous activator botrocetin. We show that botrocetin switches the mutant A1 back toward the wild-type conformation, suggesting that affinity is enhanced by augmenting the GpIb binding surface rather than through allosteric control. Functional studies of platelet adhesion under flow further suggest that the activation mechanism is distinct from that of the gain-of-function mutation.
PubMed: 12121649
DOI: 10.1016/S0969-2126(02)00787-6
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.8 Å)
構造検証レポート
Validation report summary of 1ijb
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon